Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Fast-track FDA designation for CX-904 by end of 2024?  | Binary | 5 | 8 months ago | ||
CytomX stock surges 30% post next CX-904 update? | Binary | 5 | 8 months ago | ||
CX-904 trials expansion to additional cancers by mid-2025? | Binary | 5 | 8 months ago | ||
Next major partnership for CytomX post-CX-904 success by 2024? | Categorical | 5 | 8 months ago | ||
CytomX stock performance vs. biotech industry by end 2024 | Categorical | 5 | 8 months ago | ||
Results of further CX-904 trials in pancreatic cancer by end of 2024 | Categorical | 4 | 8 months ago |